Kingfisher Shares Rise as BQ Weathers Easter Sales Dip Eyes Heatwave Recovery Copper Tariff Speculation Resurges Disrupting Global Supply Flows Prediction Market Platforms Face Legal Challenges as 16 States Escalate Regulatory Battle Sebi Proposes Intraday Option Strike Additions to Aid Volatility Navigation Why the Cost of Everyday Essentials Has Surged The Case of Eggs Ryan Cohen Eyes eBay Acquisition with GameStops Balance Sheet Firepower JELDWEN Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions TDAY Q1 2026 Earnings Surprise Profit Defies Expectations CubeSmart Q1 2026 Earnings EPS Beats Estimates by 141 Stock Slips Slightly CETY Q4 2024 Earnings Net Loss of 002 Per Share Stock Unchanged Amid Minimal Disclosure LTC Properties Inc Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter PTON Q1 2026 Earnings EPS Miss Masks Optimism Stock Surges 1023 Black Diamond Therapeutics BDTX Shares Tumble Nearly 35 on Clinical Setback Eagle Point Income Preferred EICA Posts Marginal Gain Stays Within Range Silicon Valley Acquisition Corp Units SVAQU Holds Steady at 1005 Consolidating Near Trust Value Kiniksa Pharmaceuticals Holds Steady Near 54 as Stock Tests Key Resistance Levels Northeast Bank NBN Gains 25 as Shares Approach Key Resistance Level Taylor Swifts Chart Dominance Stalled Ordinary Blocks The Fate of Ophelia for 12 Weeks on Adult Contemporary DCTH Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Continued Commercial Progress Southern Company Junior Subordinated Notes SOJD Hold Steady Near Resistance Amid Stable Trading Soluna Holdings Q4 2025 Earnings EPS Misses Estimates as Revenue Remains Absent EBMT Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Mobile Infrastructure Corporation BEEP Q1 2026 Earnings Narrow EPS Beat Fails to Stem Stock Decline NMRA Q1 2026 Earnings NarrowerthanExpected Loss Reflects Disciplined Spending Sidus Space SIDU Q1 2026 Earnings Net Loss Per Share of 008 as Stock Surges 2397 Arvinas Inc ARVN Q1 2026 Earnings Narrower Loss Beats Expectations as Clinical Pipeline Advances FMX Q1 2026 Earnings Profit Falls Sharply Short of Street Estimates